Jump to Navigation
Quantitative
Research
Quantitative Models
Methodology Graphic
EQR White Paper
Investment
Products
Baker's Dozen Model Portfolio
UITs
ETFs
Investor
Tools
Scorecards
Earnings Busters
Sector Detector
Advisors &
Individual Investors
Go to Investors Site
About Us
Our Company
Our People
ADV2A
Contact Us
Search form
Search
You are here:
You are here
Home
Aquestive Therapeutics: Biology Validated, Packaging Pending - A Forensic Analysis Of The Anaphylm CRL
Seeking Alpha
-
Tue, 02/17/2026 - 14:15
Safran: Aftermarket Power And Margin Expansion Justify Strong Buy (Rating Upgrade)
Seeking Alpha
-
Tue, 02/17/2026 - 14:09
Data Update 6 For 2026: In Search Of Profitability
Seeking Alpha
-
Tue, 02/17/2026 - 14:03
Krystal: Profitable Growth And The Expanding Reach Of HSV-1 Technology
Seeking Alpha
-
Tue, 02/17/2026 - 14:02
ECC And OXLC: Highway To The Danger Zone
Seeking Alpha
-
Tue, 02/17/2026 - 14:01
Otter Tail Corporation 2025 Q4 - Results - Earnings Call Presentation
Seeking Alpha
-
Tue, 02/17/2026 - 14:01
The Invesco Global Clean Energy ETF Could Offer Value In February 2026
Seeking Alpha
-
Tue, 02/17/2026 - 14:00
Knife River targets $3.3B–$3.5B revenue and $520M–$560M adjusted EBITDA for 2026 while advancing vertical integration strategy
Seeking Alpha
-
Tue, 02/17/2026 - 13:56
Enbridge downgraded at Jefferies after Canadian midstream's YTD rally
Seeking Alpha
-
Tue, 02/17/2026 - 13:53
Apple makes AI push with trio of new and updated devices: report
Seeking Alpha
-
Tue, 02/17/2026 - 13:47
Ethereum At Risk Of Falling Under $996
Seeking Alpha
-
Tue, 02/17/2026 - 13:46
FDVV: The Trade Off In 2026 And Beyond
Seeking Alpha
-
Tue, 02/17/2026 - 13:45
Compass Pathways: Stock Soars As Data Sets Up Psilocybin Approval Shot
Seeking Alpha
-
Tue, 02/17/2026 - 13:43
Danaos: Alaska LNG Investment - Smart Diversification Or Opportunity Cost?
Seeking Alpha
-
Tue, 02/17/2026 - 13:41
Tyler Technologies: Bookings Decline And An Unattractive Price
Seeking Alpha
-
Tue, 02/17/2026 - 13:40
Volatility watch: Wingstop is setting up for a big earnings move
Seeking Alpha
-
Tue, 02/17/2026 - 13:36
Harmony Bio granted FDA label expansion for Wakix in children with narcolepsy
Seeking Alpha
-
Tue, 02/17/2026 - 13:35
Vulcan Materials targets $2.4B–$2.6B adjusted EBITDA in 2026 as public and private demand improves
Seeking Alpha
-
Tue, 02/17/2026 - 13:35
Albemarle raised to Buy at BofA as market improvement looks increasingly structural
Seeking Alpha
-
Tue, 02/17/2026 - 13:34
COMPASS Pathways plc (CMPS) Discusses Positive Phase III Results for COMP360 in Treatment-Resistant Depression Trials - Slideshow
Seeking Alpha
-
Tue, 02/17/2026 - 13:32
Pages
« first
‹ previous
…
2127
2128
2129
2130
2131
2132
2133
2134
2135
…
next ›
last »